LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Enters Into Master Commercial Supply and Services Agreement With Otsuka
27 oct. 2021 07h00 HE | Recro Pharma, Inc.
Agreement Establishes Recro as Commercial Supplier for Otsuka Deal Validates Recro’s “Second Source” Strategy of Supporting Commercial Programs as U.S.-Based Supplier GAINESVILLE, Ga. and SAN...
Esperion Logo (primary).png
Esperion Announces Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of NEXLETOL™ (bempedoic acid) and NEXLIZET™ (bempedoic acid and ezetimibe) Tablets in Japan
20 avr. 2020 07h00 HE | Esperion Therapeutics, Inc.
–  Esperion to Receive $60 Million Upfront Payment  – –  Up to $510 Million in Total Milestones  – –  Substantial Tiered Royalties  – –  Combines Esperion’s Expertise in Lipid Management with...
OM_Logo-4c.jpg
Otsuka Pharmaceutical Development & Commercialization, Inc. Develops Relapse Risk Assessment For Schizophrenia Patients (RASP): A New Self-Report Screening Tool
09 mai 2018 23h01 HE | Open Minds
Gettysburg, PA, May 09, 2018 (GLOBE NEWSWIRE) -- Nearly 3.4 million adults, or 1.1% of the U.S. population, are affected by schizophrenia.1,2 As a chronic, relapsing condition, those who have...
OM_Logo-4c.jpg
2017 OPEN MINDS Technology & Informatics Faculty List Announced; Includes Leaders From Over 30 Influential Health & Human Service Organizations
17 oct. 2017 07h30 HE | Open Minds
Gettysburg, PA, Oct. 17, 2017 (GLOBE NEWSWIRE) -- OPEN MINDS recently announced the faculty list for this year’s 2017 OPEN MINDS Technology & Informatics Institute taking place on November 7-8,...
Cutting Edge Information Analyzes the Bristol-Myers Squibb / Otsuka Pharma Profit-Sharing Strategy for 2010 and Beyond
16 avr. 2009 10h17 HE | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - April 16, 2009) - The recently announced deal between Bristol-Myers Squibb and Otsuka over Abilify will go a long way toward shoring up both companies'...